Literature DB >> 8349072

[Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].

Y Bacq1, Y Schillio, J F Brechot, A De Muret, F Dubois, E H Metman.   

Abstract

Serum levels of haptoglobin, an acute phase protein, in usually increased in patients with inflammation and decreased in patients with intravascular hemolysis. Changes in haptoglobin serum levels were also observed in patients with liver disease. The aim of this study was to evaluate the serum level of haptoglobin in patients with chronic viral hepatitis C. Haptoglobin serum levels were measured by rate nephelometry in 34 patients with histologically proven chronic viral hepatitis C and in 30 controls. Haptoglobin serum levels were lower in patients than in controls (0.56 +/- 0.36 versus 0.90 +/- 0.35 g/L, P < 0.001). In patients with chronic hepatitis but without cirrhosis, haptoglobin serum levels were decreased as well. Haptoglobin serum levels were positively correlated to prothrombin index (P < 0.001) and negatively correlated to the histology activity index of Knodell (P < 0.001), and especially to scores of fibrosis (P < 0.001) and periportal necrosis (P < 0.05). Red cell count, indirect bilirubin level, and reticulocyte count, as markers of hemolysis, were similar in patients and controls. We conclude that determination of haptoglobin serum levels may be useful in the evaluation and the follow-up of patients with chronic viral hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349072

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  7 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia.

Authors:  Maria Atta; Milena Cabral; Gilvan Santos; Raymundo Paraná; Ajax Atta
Journal:  Inflamm Res       Date:  2012-06-21       Impact factor: 4.575

3.  Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

Authors:  Robert P Myers; Mercedes De Torres; Françoise Imbert-Bismut; Vlad Ratziu; Frédéric Charlotte; Thierry Poynard
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

4.  A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels.

Authors:  Philippe Froguel; Ndeye Coumba Ndiaye; Amélie Bonnefond; Nabila Bouatia-Naji; Aurélie Dechaume; Gérard Siest; Bernard Herbeth; Mario Falchi; Leonardo Bottolo; Rosa-Maria Guéant-Rodriguez; Cécile Lecoeur; Michel R Langlois; Yann Labrune; Aimo Ruokonen; Said El Shamieh; Maria G Stathopoulou; Anita Morandi; Claudio Maffeis; David Meyre; Joris R Delanghe; Peter Jacobson; Lars Sjöström; Lena M S Carlsson; Andrew Walley; Paul Elliott; Marjo-Riita Jarvelin; George V Dedoussis; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Authors:  Seham M Ragab; Manal A Safan; Eman A Badr
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-15       Impact factor: 2.576

6.  Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine.

Authors:  Jeerang Wongtrakul; Thananya Thongtan; Sittiruk Roytrakul; Benjawan Kumrapich; Kanokwan Janphen; Jutarat Praparattanapan; Khuanchai Supparatpinyo; Duncan R Smith
Journal:  Dis Markers       Date:  2014-12-17       Impact factor: 3.434

7.  Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease.

Authors:  Han Hyo Lee; Yeon Seok Seo; Soon Ho Um; Nam Hee Won; Hanna Yoo; Eun Suk Jung; Yong Dae Kwon; Sanghoon Park; Bora Keum; Yong Sik Kim; Hyung Joon Yim; Yoon Tae Jeen; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.